Dove Scalp + Hair Therapy: Product Education as a Premiumisation Strategy

Industry & Competitive Context

The global hair and scalp care market was valued at approximately $103.94 billion in 2024, with industry forecasts projecting annual growth of around 6.4% through 2030, driven substantially by demand for scalp care and anti-dandruff solutions. Unilever has described this shift as the "skinification" of hair care — the application of skincare-grade ingredients, dermatological validation, and clinical testing methodologies to a category historically sold on cosmetic benefits such as shine, softness, and fragrance.

Within Unilever's portfolio architecture, Dove sits inside the Beauty & Wellbeing division, alongside brands such as Vaseline, TRESemmé, Sunsilk, Clear, Hourglass, Nutrafol, and Liquid I.V. Unilever's stated strategic priorities for this division are threefold: premiumising the core Hair Care and Skin Care portfolio, expanding Prestige Beauty and Wellbeing through selective international rollout, and strengthening competitiveness through science-led innovation combined with a "social-first" approach to consumer engagement. Dove's hair care initiatives from 2024 onward — Scalp + Hair Therapy, Damage Therapy, Derma Scalp, and The Art of Repair — sit squarely within the first of these priorities.

Competitively, mass-market hair care has increasingly borrowed positioning language from prestige skincare and dermatology, with brands competing on ingredient transparency, clinical substantiation, and "root cause" narratives (scalp health as the driver of hair outcomes) rather than purely aesthetic claims. This has raised the bar for what counts as credible product education in the category.

Brand Situation Prior to the Campaign

Dove entered this cycle of hair care innovation as an already well-established mass brand with decades of equity built primarily around its skin cleansing and "Real Beauty" positioning. Its Chief Scientist function had, according to company communications, drawn on "65 years of Dove science and expert care." However, prior to the 2024 relaunch, Dove's hair portfolio was positioned largely as a daily-care essential rather than as an authority in specific, dermatologically framed problems such as scalp barrier health, hair density, or protein damage repair.

Unilever's own investor commentary frames the pre-campaign period as one in which Hair Care as a category was growing only in the mid-single digits, while the broader Beauty & Wellbeing division was seeking to lift the category into higher-margin, premium territory. Unilever's Fabian Garcia, President of Personal Care, described the strategic imperative in the FY2024 20-F filing as "winning with science-led, premium products and leveraging partnerships." This signals that, ahead of the campaigns discussed below, Dove hair care was viewed internally as underleveraged relative to its brand equity and R&D capability.

Strategic Objective

Based on Unilever's public statements, Dove's hair care initiatives from 2024–2026 pursued three interlocking objectives:

1. Elevate Dove hair care from a functional, daily-use category into an authority position on specific, science-backed outcomes — scalp health, hair density, and damage repair — rather than generic cleansing and conditioning.

   
   

2. Justify premium pricing and margin expansion by pairing clinical substantiation (dermatologist co-creation, clinical trial data, proprietary technology names such as Bio-Protein Care) with elevated packaging and in-store presentation.

   
   

3. Educate consumers on the causal mechanics of hair health — for example, that hair is approximately 90% protein and that daily damage strips this protein away — so that consumers understand why a given product or regimen is needed, not merely that it exists. This is the explicit "product education" dimension of the campaigns: content and tools designed to inform consumers' understanding of scalp and hair biology before, and alongside, the sell.

   
   

Unilever's Beauty & Wellbeing Chief Marketing Officer, Leandro Barreto, described the broader premiumisation logic behind these launches as helping brands "enhance brand perception, foster stronger brand loyalty, achieve higher margins, and tap into fast-growing demand for high-quality, differentiated products," while noting that innovation is "the engine of premiumisation."

Campaign Architecture & Execution

Dove's hair therapy education effort was not a single advertising campaign but a sequence of coordinated product launches, each anchored in a scientific narrative and supported by consumer-facing educational assets:

Dove Scalp + Hair Therapy (March 2024). Launched nationally in the United States, this collection reframed hair health as beginning at the scalp. The line was developed with dermatologists and described by Unilever as "clinically proven," citing an independent 90-day clinical trial of 74 women in which 89% reported feeling their hair was thicker and stronger, alongside smaller salon studies of 40 women each. Central to the education strategy was the Dove AI Scalp + Hair Therapist, an interactive 12-question digital assessment tool that recommended specific products after learning about a user's hair type and goals — effectively converting product education into a personalised, self-service diagnostic experience rather than a one-way advertising message. Brian Kennedy, Chief Operating Officer of Unilever North America Beauty and Wellbeing, and Beth Labrecque, Principal Scientist for Dove, were both quoted in official press materials explaining the scientific rationale and consumer insight behind the launch.

Dove Damage Therapy / Intensive Repair (2025). This premium range was positioned around a proprietary "Bio-Protein Care" technology, developed, according to Unilever, "over ten years" by R&D scientists at Unilever's Materials Innovation Factory. The consumer education hook was a simple biological fact repeated across owned channels: hair is roughly 90% protein, and this protein is depleted by heat styling and colouring. The campaign used the tagline "You and your hair, reborn stronger" and incorporated the Japanese art motif of Kintsugi — the practice of repairing broken pottery with molten gold — as a visual and narrative device to communicate the idea of repaired hair being stronger at the point of repair. Execution leaned on a "social-first" strategy, partnering with influencers and content creators to distribute stories of personal resilience alongside the product's technical claims.

Dove Derma Scalp and The Art of Repair (2026). Building on the scalp-first thesis, Dove extended the "skinification" narrative internationally (with Derma Scalp launching first in Mexico before wider rollout) and introduced a limited-edition, Walmart-exclusive collection, The Art of Repair, using fine-art conservation as a metaphor for hair restoration. This launch was underpinned by what Unilever called the "Bridges Study," described as incorporating both clinical and consumer research across 1,400 participants using multiomics analysis (genes, proteins, and metabolites) to link laboratory-measured scalp biology with consumers' subjective perception of results — a methodological attempt to make product education claims independently verifiable rather than purely promotional.

Across all three waves, the consistent educational architecture included: (a) a plain-language biological premise (protein loss, scalp barrier health, dandruff mechanisms), (b) named, quasi-branded technology (Bio-Protein Care, proteomic mapping), (c) dermatologist or scientist co-creator credentials disclosed by name and title, and (d) publicly cited clinical or consumer study sample sizes.

Positioning & Consumer Insight

The consumer insight underlying these campaigns, as articulated in Unilever's own communications, is that "women are increasingly prioritizing scalp care, recognizing it as a vital step in their hair health routine" and are seeking products that are "affordable, effective, and backed by science." This reflects a broader premiumisation insight Unilever has applied across its beauty portfolio: that consumers are "increasingly value-conscious, seeking products that offer a taste of luxury without the luxury price tag" — described internally using the term "masstige" (mass + prestige).

The positioning strategy therefore did not attempt to reposition Dove as a luxury brand outright. Instead, it layered dermatological credibility and ingredient-level education onto Dove's existing equity of accessibility and trust — evidenced by price points such as a $9.99 suggested retail price per product in the Scalp + Hair Therapy line, sold through mass retailers including Amazon, Target, Walmart, CVS, and Walgreens. This is consistent with Unilever's own description of masstige as being about "elevating a product's value through science" while remaining within a broadly accessible price band.

Separately, Dove's long-running purpose platform — the Dove Self-Esteem Project and the CROWN Movement, which addresses textured and Black hair representation and hair-based discrimination — provided an adjacent, non-transactional educational layer. Dove describes the Self-Esteem Project as "the biggest provider of self-esteem education in the world," with a stated goal to educate 250 million young people by 2030, and states a policy of representing women "with zero digital distortion" and never using AI to alter people in its marketing. While this purpose-driven education operates on a separate track from the product-specific scalp and damage therapy education, both draw on a shared brand principle of positioning Dove as an authoritative, trustworthy source of information rather than a purely aspirational beauty brand.

Media & Channel Strategy

Publicly available material verifies the following channel and distribution elements:

• Owned digital channels: Dove.com hosts a dedicated "Stories" and "Campaigns" section featuring named dermatologists (including Dr. Lina Kennedy, Dr. Yolanda M. Lenzy, and Dr. Joyce Park, each credited as co-creators of the Scalp + Hair Therapy Density Boost line) authoring consumer-facing educational content on topics such as normal shedding versus hair loss and scalp health fundamentals.

  
  

• Retail distribution: Scalp + Hair Therapy launched simultaneously in-store and online at Amazon, Target, Walmart, CVS, and Walgreens.

  
  

• Retail exclusivity as a media vehicle: The Art of Repair collection was distributed as a Walmart-exclusive limited edition, using distinctive packaging (black bottles with gold trim, art-gallery-inspired design) explicitly designed, per Unilever, to "stand out on shelf" — treating packaging itself as a communication and education medium at the point of purchase.

  
  

• Social-first influencer strategy: For Damage Therapy, Unilever's own release states the brand "partnered with influencers and content creators" to distribute a campaign "rooted in cultural insights" around personal resilience narratives.

  
  

• Interactive tools: The Dove AI Scalp + Hair Therapist functioned as a direct-response education and product-matching mechanism embedded in digital retail and owned-media touchpoints.

Business & Brand Outcomes

Unilever's public financial disclosures provide the clearest verified evidence of outcomes tied to this initiative:

• In its Q4 and Full Year 2024 results announcement, Unilever stated that Dove "delivered high-single digit volume-led growth following the launch of Scalp + Hair Therapy, designed for improved scalp health and hair density," within a Hair Care category that grew mid-single digit overall for the year.

  
  

• In Q1 2025, Unilever reported "double-digit growth from both Vaseline and Dove," attributed to "premium launches in the Americas."

  
  

• In its Q3 2025 trading update, Unilever reported that Beauty & Wellbeing underlying sales grew 5.1% for the period, with growth "accelerat[ing] versus the first half, led by double-digit growth in Dove hair, Vaseline, Liquid I.V., Nutrafol, Hourglass, and K18."

  
  

• In its FY2025 Form 20-F filed with the SEC, Unilever confirmed that while overall Hair Care category sales were flat for the year, "Dove delivered double-digit growth driven by the successful launch of its renovated hair care range," even as the broader category was affected by softness in Sunsilk and Clear in certain emerging markets.

  
  

• Beauty & Wellbeing as a division reported combined turnover of €12.8 billion for FY2025, with Unilever explicitly citing "premiumisation" and "continued investment behind brands such as Dove" as growth drivers.

Strategic Implications

The Dove Scalp + Hair Therapy initiative illustrates a broader principle in mature FMCG categories: incremental category growth increasingly requires reframing a functional product around new, dermatologically credible problem statements (scalp barrier health, protein loss) rather than iterating on existing use occasions. By pairing named scientific credentials, disclosed clinical sample sizes, and interactive diagnostic tools with an accessible mass-retail price point, Dove pursued margin-accretive "masstige" growth without abandoning the accessibility that underpins its core brand equity.

The sequencing of launches — Scalp + Hair Therapy (2024), Damage Therapy (2025), Derma Scalp and The Art of Repair (2026) — also suggests a deliberate cadence of innovation designed to sustain "double-digit growth" narratives across multiple reporting periods, consistent with Unilever's stated strategy of "scal[ing] multi-year innovation" programmes across its Power Brands. This raises a structural question relevant to marketing strategy more broadly: whether repeated premium sub-brand launches within a single mass brand risk diluting a singular "Dove hair" positioning, or whether — as Unilever's own results to date indicate — they function as a renewable engine for volume and price-led growth within a single master brand architecture.

Finally, the consistent presence of named dermatologists, disclosed study populations, and plain-language biological explanations (e.g., "hair is 90% protein") across every wave of communication indicates that, for this category and this brand, credibility-building product education has become a prerequisite for premium claims to be accepted by both consumers and retail partners — not merely a supporting communications tactic.

Discussion Questions

1. Dove's product education strategy pairs dermatological credibility (named scientists, disclosed clinical sample sizes) with a mass-market price point. What are the risks and benefits of this "masstige" approach compared with either a fully premium repositioning or a purely functional mass-market claim?

   
   

2. Unilever discloses category-level and brand-level underlying sales growth but not campaign-specific ROI. As a marketing leader, how would you design an internal measurement framework to isolate the incremental contribution of a specific product education campaign (e.g., the Dove AI Scalp + Hair Therapist tool) from concurrent pricing and distribution actions?

   
   

3. Dove launched three distinct "therapy"-branded innovation waves (Scalp + Hair Therapy, Damage Therapy, Derma Scalp/Art of Repair) within roughly two years. What are the strategic trade-offs between sustaining growth through frequent sub-brand innovation versus the risk of positioning fragmentation within a single master brand?

   
   

4. The Dove AI Scalp + Hair Therapist tool converts product education from one-way advertising into an interactive, personalised diagnostic experience. How does this shift change the marketing funnel, and what capabilities (data, technology, retail partnerships) does a brand need to execute this at scale?

   
   

5. Dove's purpose-driven platforms (the Self-Esteem Project, the CROWN Movement) and its product-specific science education (scalp barrier health, protein loss) operate on separate but parallel tracks. Should these be integrated into a single brand narrative, or is there strategic value in keeping purpose-led and product-led education distinct?